OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.520
+0.050 (3.40%)
At close: Sep 1, 2026, 4:00 PM EDT
1.515
-0.005 (-0.33%)
After-hours: Sep 1, 2026, 4:48 PM EDT
OPKO Health Employees
OPKO Health had 2,275 employees as of December 31, 2025. The number of employees decreased by 722 or -24.09% compared to the previous year.
Employees
2,275
Change (1Y)
-722
Growth (1Y)
-24.09%
Revenue / Employee
$258,416
Profits / Employee
-$32,040
Market Cap
1.13B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,275 | -722 | -24.09% |
| Dec 31, 2024 | 2,997 | -933 | -23.74% |
| Dec 31, 2023 | 3,930 | -266 | -6.34% |
| Dec 31, 2022 | 4,196 | -1,571 | -27.24% |
| Dec 31, 2021 | 5,767 | 498 | 9.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| NeoGenomics | 2,500 |
| Fulgent Genetics | 1,315 |
| GeneDx Holdings | 1,300 |
| Castle Biosciences | 1,002 |
| GRAIL | 910 |
| CareDx | 765 |
| Veracyte | 755 |
OPK News
- 19 days ago - OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests - GlobeNewsWire
- 4 weeks ago - Cocrystal Pharma announces $5M investment from Opko Health - TheFly
- 4 weeks ago - Cocrystal Pharma announces $5M private placement with Opko Health - TheFly
- 5 weeks ago - Opko Health sees Q3 revenue $131M-$142M, consensus $134.65M - TheFly
- 5 weeks ago - Opko Health sees FY26 revenue $560M-$585M, consensus $536.88M - TheFly
- 5 weeks ago - Opko Health reports Q2 EPS (1c), one estimate (11c) - TheFly
- 5 weeks ago - OPKO Health Earnings Call Transcript: Q2 2026 - Transcripts
- 5 weeks ago - OPKO Health Earnings release: Q2 2026 - Filings